Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • lwhitmore
    Member
    • Aug 2013
    • 70

    #1

    -s=reverse HTSEQ option

    Hi,
    When using the -s=reverse option for HTSEQ most reads counted are mapped to anti-sense strand of the gene. How does this option work and what exactly is it doing?

    Thanks,
    Leanne
  • apredeus
    Senior Member
    • Jul 2012
    • 151

    #2
    some library-prep methods result in "strand reversal" - basically your cDNA reads map to the strand opposite to where actual gene is. So if you're not sure what library prep was used, run Picard's CollectRNAseqMetrics on your experiment, and see what percent of the mapped reads matches that of the "feature" (that is, annotated gene). If you get something like 50%, use unstranded option. If you get 100%, use stranded. And if you get about 0%, use reverse.

    This holds true not only for htseq but also for RSEM and all other strand-aware Rna-Seq quantifiers

    Comment

    • lwhitmore
      Member
      • Aug 2013
      • 70

      #3
      right so if we know that we have strand reversed library and we use the option -s reverse then reads will only be counted if they map to the apposing strand that the feature "gene" is actually on correct?

      Thanks
      Leanne
      Last edited by lwhitmore; 03-21-2016, 08:16 PM.

      Comment

      • apredeus
        Senior Member
        • Jul 2012
        • 151

        #4
        Well if you are using -s reverse, the reads landing on the transcript in the same direction as the transcript should NOT be counted. Really, what you should do is run quantification on your library with all three options and see what sort of numbers you get. Say, for example, if you had 40M aligned reads, of which 32M land on the annotated transcripts, you should get the sum total of all genes as follows:

        - s no = 32 M
        - s reverse = 30-31 M
        - s yes = 1-2 M

        if that's not what you see, you need to dig into your data and see what went wrong.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        17 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        25 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-13-2026, 09:56 AM
        0 responses
        22 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-09-2026, 11:14 AM
        0 responses
        27 views
        0 reactions
        Last Post SEQadmin2  
        Working...